App-Quantinova.ai

Kruppel-Like Factors in Thrombosis and Hemostasis

Mukesh Jain - American Society of Hematology (ASH) , 2018

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Venous thrombosis

N/A

Platelet Biogenesis in the Lung Circulation

Mark Looney - American Society of Hematology (ASH) , 2018

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Venous thrombosis

N/A

Spatial Regulation of Thrombopoiesis in the Bone Marrow

David Stegner - American Society of Hematology (ASH) , 2018

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Venous thrombosis

N/A

The Pros and Cons of Splenectomy in Transfusion Dependent Thalassemia Patient

Adisak Tantiworawit - American Society of Hematology (ASH) , 2018

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Venous thrombosis

N/A

Clinical-Pathological Features of Non-Transfusion Dependent Thalassemia in Adults — a Single Center Study in Hong Kong

Ka Lok Luke Chan - American Society of Hematology (ASH) , 2018

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Venous thrombosis

N/A

Familial Polycythemia Likely Due to Novel Hemoglobin Variant Hemoglobin Hyden

Sandhya Kolagatla - American Society of Hematology (ASH) , 2018

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Venous thrombosis

Erythropoietin

Correlation of Circulating Microparticles with Coagulation and Fibrinolysis Is Healthy Individuals

Venencia Albert - American Society of Hematology (ASH) , 2018

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Venous thrombosis

Phosphatidylserine

Incidence of Thromboembolic Disease in Hereditary Hemorrhagic Telangiectasia (Osler Weber Rendu Syndrome)

Marcelo Martin Serra - American Society of Hematology (ASH) , 2018

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Venous thrombosis

N/A

Medical Decision Analysis: Choosing Second Line Treatment in Adults with Immune Thrombocytopenia (ITP)

Barbara Skopec - American Society of Hematology (ASH) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Venous thrombosis

Mycophenolate mofetil

Comparison of Rivaroxaban with Argatroban in Heparin Induced Thrombocytopenia Using Historical Controls : A Case-Control Study

Vivek Suresh Modi - American Society of Hematology (ASH) , 2018

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Venous thrombosis

rivaroxaban

Bleeding Severity and Health Care Utilization in Patients with Platelet Function Disorders

Divyaswathi Citla Sridhar - American Society of Hematology (ASH) , 2018

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Venous thrombosis

N/A

the Importance of CD36 Expression in Evaluation of Thrombotic Risk in Patients with Myeloproliferative Neoplasms

Viola Popov - American Society of Hematology (ASH) , 2018

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Venous thrombosis

N/A

Description of the First Cases with ADAMTS13 Mutations in Hungary

Marienn Rti - American Society of Hematology (ASH) , 2018

Therapeutic Area

Disease

Drug/Treatment

Nephrology

Venous thrombosis

Heparin

The Value of FDP/FIB and D-Dimer/FIB Ratios: Predicting High-Risk APL Related Thrombosis

Yanliang Bai - American Society of Hematology (ASH) , 2018

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

Tretinoin

Hypofibrinogenemia in Patient with Extended Exposure to Argatroban Therapy

Mustafa Saudi - American Society of Hematology (ASH) , 2018

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Venous thrombosis

Tenecteplase

Risk Factors of Thromboembolic Disease in Men with Prostate Cancer: Report from a Hispanic Population

Rodrigo Luna-Santiago - American Society of Hematology (ASH) , 2018

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Venous thrombosis

N/A

Molecular and Clinical Aspects of Aα Dysfibrinogenemia in 25 Patients from the Czech Republic

Eliska Ceznerova - American Society of Hematology (ASH) , 2018

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Venous thrombosis

Fibrinogen (IV)

Lipoprotein(a) a Risk Factor for Venous Thrombosis and Pulmonary Embolism in Patients Younger Than 50 Years of Age

Sonha Nguyen - American Society of Hematology (ASH) , 2018

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Venous thrombosis

Protein C

Weight-Based Enoxaparin Dosing for Venous Thromboembolism (VTE) >100kg Gives Similar Anti-Xa Levels to Patients <100kg, with No Increase in Bleeding

Kylee H Maclachlan - American Society of Hematology (ASH) , 2018

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Venous thrombosis

Enoxaparin

Recurrent Venous Thromboembolism (VTE), Major Bleeding (MB), and Associated Cost of Treatment with Low Molecular Weight Heparin (LMWH) or Direct Oral Anticoagulant (DOAC) in High Risk Patients with Gastrointestinal (GI) Malignancies: Retrospective Real-World Analysis at a Comprehensive Cancer Center

Alejandro Recio Boiles - American Society of Hematology (ASH) , 2018

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Venous thrombosis

Heparin

Filters

7277 Abstracts